SEC Says Market Forecaster Ran Biotech Pump-And-Dump

By Emilie Ruscoe

The U.S. Securities and Exchange Commission has sued a subscription-based investment advice company and its owner, accusing them of making nearly $1.4 million in a pump-and-dump scheme involving a purported drugmaker.

 Complaint attached | Read full article » | Save to favorites »